NCT04638049View on ClinicalTrials.gov

Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT)

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

August 8, 2022

Study Completion Date

August 8, 2022

Conditions
Prostate CancerProstate AdenocarcinomaProstatic Neoplasms
Interventions
OTHER

Collection of human biofluids

Feces, blood and urine: (1) shortly before, (2) during and (3) shortly after RT treatment, as well as (4) one-month post-RT

OTHER

Patient reported outcome measures

EORTC QLQ-C30, PR25: (1) shortly before and (2) shortly after RT treatment, as well as (3) one-month post-RT

Trial Locations (1)

9000

Ghent University Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT04638049 - Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT) | Biotech Hunter | Biotech Hunter